Meril Meriscreen IgG/IgM Dengue Rapid Card

Dual Antibody Detection: This rapid card is specifically
designed to simultaneously detect both IgG and IgM antibodies against the
Dengue virus. This dual capability provides a holistic view of the patient's
immune response, aiding in the determination of the infection stage.

Swift Results: With results available in just minutes,
healthcare professionals can promptly initiate appropriate treatment and
monitor disease progression.

High Sensitivity and Specificity: The Meriscreen Rapid Card
is engineered for exceptional sensitivity and specificity, reducing the risk of
false positives or negatives and ensuring reliable results.

User-Friendly: Simple to use and requiring minimal
training, this test is suitable for a range of healthcare settings, including
clinics, hospitals, and even fieldwork in resource-limited areas.

Quality Assurance: Manufactured by Meril, a trusted name in
healthcare, this rapid card adheres to stringent quality standards,
guaranteeing consistent and reliable performance.

Cost-Efficient: With 20 tests per pack, this product offers
outstanding value for healthcare facilities. It empowers healthcare providers
to conduct widespread Dengue screening economically.

Global Impact: By enabling early diagnosis and facilitating
timely patient management, this rapid card plays a crucial role in reducing the
severity of Dengue cases and preventing its spread, making a significant
contribution to global Dengue control efforts.